Remala Abadi Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp2,450 (market cap 3.29T, 15.47M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 4.6× Charlie Hospital Semarang Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 15.47M). Which is the better fit depends on your goals.
| DATA | RSCH | |
|---|---|---|
Market Cap | 3.29T | 715.5B |
Volume | 15.47M | 30.64M |
Lot | 154.74K | 306.41K |
Turnover | 37.99B | 7.98B |
Average Price | 2,454.89 | 260.34 |
Value | 37.99B | 7.98B |
Indicative Equilibrium Price | 2,450 | 256 |
Indicative Equilibrium Volume | 2.17K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →